Metabolic cardiovascular syndrome after renal transplantation

Nephrology Dialysis Transplantation

Volumn 16, Issue 5, 2001, Pages 1047-1052

  Hjelmesæth, Jøran ^a,b   Hartmann, Anders ^a   Midtvedt, Karsten ^a   Aakhus, Svend ^a   Stenstrøm, Jean ^a   Mørkrid, Lars ^a   Egeland, Thore ^a   Tordarson, Hrafnkell ^a   Fauchald, Per ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Vestfold Central Hospital   (Norway)

Author keywords

Cardiovascular disease; Cardiovascular metabolic syndrome; Dyslipidaemia; Post transplant diabetes mellitus; Post transplant glucose intolerance; Renal transplantation

Indexed keywords

APOLIPOPROTEIN B; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; DIURETIC AGENT; FUROSEMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PREDNISOLONE; STEROID; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GRAFT REJECTION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; KIDNEY TRANSPLANTATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; POPULATION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RECIPIENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0343337579     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.5.1047     Document Type: Article

References (22)

1. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165
2. Aakhus S, Dahl K, Widerøe TE. Cardiovascular morbidity and mortality in renal transplant recipients. Results from a 5-year follow-up [Abstract]. Nephrol Dial Transplant 1997; 12: A231
3. Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
4. Harris MI. Impaired glucose tolerance in the U.S. population. Diabetes Care 1989; 12: 464-474
5. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. Circulation 1998; 98: 398-404
6. Bjørnholt JV, Erikssen G, Aaser E et al. Fasting blood glucose: An underestimated risk factor for cardiovascular death. Diabetes Care 1999; 22: 45-49
7. Turner RC, Millns H, Neil HAW et al. Risk factors for coronary heart disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) BMJ 1998; 316: 823-828
8. Ekstrand AV, Eriksson JG, Grönhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplant diabetes in man. Transplantation 1992; 53: 563-569
9. Midtvedt K, Hartmann A, Hjelmesæth J, Lund K, Bjerkely BL. Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients. Nephrol Dial Transplant 1998; 13: 427-431
10. Hjelmesæth J, Hartmann A, Kofstad J et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979-983
11. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925-926
12. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197
13. Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG. Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 1998; 31: 28-34
14. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteinc in plasma and serum. Eur J Clin Biochem 1991; 29: 549-554
15. Aker S, Ivens K, Guo Z, Grabensee B, Heering P. Cardiovascular complications after renal transplantation. Transplant Proc 1998; 30: 2039-2042
16. Lusis AJ, Weinreb A, Drake TA. Genetics of atherosclerosis. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Lippincott Raven, Philadelphia, 1998; 2389-2413
17. Lamarche B, Tchernof A, Mauriège P et al. Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961
18. Rajman I, Harper L, McPake D, Kendall MJ, Wheeler DC. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant 1998; 13: 2281-2287
19. Arnadottir M, Hultberg B, Wahlberg J, Fellström B, Dimény E. Serum total homocysteine concentration before and after renal transplantation. Kidney Int 1998; 54: 1380-1384
20. Markell MS, Armenti V, Danovitch G, Sumrani N. Hyperlipidemia and glucose intolerance in the post-renal transplant patient. J Am Soc Nephrol 1994; 4: S37-47
21. First MR, Neylan JF, Rocher LL, Tejani A. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4 [Suppl. 8]: S30-36
22. Hricik DE, Schulak JA. Metabolic effects of steroid withdrawal in adult renal transplant recipients. Kidney Int 1993; 44 [Suppl. 43]: S26-29